Literature DB >> 15619635

The DeltaF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR.

Kai Du1, Manu Sharma, Gergely L Lukacs.   

Abstract

Misfolding accounts for the endoplasmic reticulum-associated degradation of mutant cystic fibrosis transmembrane conductance regulators (CFTRs), including deletion of Phe508 (DeltaF508) in the nucleotide-binding domain 1 (NBD1). To study the role of Phe508, the de novo folding and stability of NBD1, NBD2 and CFTR were compared in conjunction with mutagenesis of Phe508. DeltaF508 and amino acid replacements that prevented CFTR folding disrupted the NBD2 fold and its native interaction with NBD1. DeltaF508 caused limited alteration in NBD1 conformation. Whereas nonpolar and some aliphatic residues were permissive, charged residues and glycine compromised the post-translational folding and stability of NBD2 and CFTR. The results suggest that hydrophobic side chain interactions of Phe508 are required for vectorial folding of NBD2 and the domain-domain assembly of CFTR, representing a combined co- and post-translational folding mechanism that may be used by other multidomain membrane proteins.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15619635     DOI: 10.1038/nsmb882

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  164 in total

1.  Allosteric modulation balances thermodynamic stability and restores function of ΔF508 CFTR.

Authors:  Andrei A Aleksandrov; Pradeep Kota; Liying Cui; Tim Jensen; Alexey E Alekseev; Santiago Reyes; Lihua He; Martina Gentzsch; Luba A Aleksandrov; Nikolay V Dokholyan; John R Riordan
Journal:  J Mol Biol       Date:  2012-03-08       Impact factor: 5.469

Review 2.  The delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiology.

Authors:  Christopher J Guerriero; Jeffrey L Brodsky
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

3.  ATP induces conformational changes in the carboxyl-terminal region of ClC-5.

Authors:  Leigh Wellhauser; Cesar Luna-Chavez; Christina D'Antonio; John Tainer; Christine E Bear
Journal:  J Biol Chem       Date:  2010-12-20       Impact factor: 5.157

4.  Fluorinated ΔF508-CFTR correctors and potentiators for PET imaging.

Authors:  Holly R Davison; Danielle M Solano; Puay-Wah Phuan; A S Verkman; Mark J Kurth
Journal:  Bioorg Med Chem Lett       Date:  2012-01-03       Impact factor: 2.823

5.  p97 functions as an auxiliary factor to facilitate TM domain extraction during CFTR ER-associated degradation.

Authors:  Eric J Carlson; David Pitonzo; William R Skach
Journal:  EMBO J       Date:  2006-09-14       Impact factor: 11.598

Review 6.  Update in cystic fibrosis 2005.

Authors:  Frank J Accurso
Journal:  Am J Respir Crit Care Med       Date:  2006-05-01       Impact factor: 21.405

7.  Cooperative assembly and misfolding of CFTR domains in vivo.

Authors:  Kai Du; Gergely L Lukacs
Journal:  Mol Biol Cell       Date:  2009-01-28       Impact factor: 4.138

8.  Processing and function of CFTR-DeltaF508 are species-dependent.

Authors:  Lynda S Ostedgaard; Christopher S Rogers; Qian Dong; Christoph O Randak; Daniel W Vermeer; Tatiana Rokhlina; Philip H Karp; Michael J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-14       Impact factor: 11.205

Review 9.  Dynamics intrinsic to cystic fibrosis transmembrane conductance regulator function and stability.

Authors:  P Andrew Chong; Pradeep Kota; Nikolay V Dokholyan; Julie D Forman-Kay
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

10.  Design and synthesis of a hybrid potentiator-corrector agonist of the cystic fibrosis mutant protein DeltaF508-CFTR.

Authors:  Aaron D Mills; Choong Yoo; Jeffrey D Butler; Baoxue Yang; A S Verkman; Mark J Kurth
Journal:  Bioorg Med Chem Lett       Date:  2009-11-13       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.